Costly catastrophic claims are emerging in the workers compensation sector, partly driven by comorbidities and prescribing of expensive brand-name drugs, experts say.
Data analysis by Aarthi Thiruvengadam Over the first few months of the COVID-19 pandemic, the workers’ compensation industry has gone thro
Brand name medications are often scrutinized by the workers’ compensation industry for their high cost.
Part Two: Evaluating In-Network and Out-of-Network Trends In this final post related to our in-network and out-of-network analysis we
Taking a multi-disciplinary approach to ongoing pain management and opioid recovery
Following up on comments received at their June 25, 2020, hearing, the Industrial Commission of Arizona released a revised version of their draft f
Over the last decade, the insurance industry has undergone dramatic changes that have catapulted it to the forefront of the American consciousness,